Gemcitabine combined with cisplatin as neoadjuvant chemotherapy in stage IB-IIIA non-small cell lung cancer. [electronic resource]
Producer: 20110823Description: 569-75 p. digitalISSN:- 1473-5741
- Adolescent
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Blood Cell Count
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Positron-Emission Tomography
- Survival Analysis
- Tomography, X-Ray Computed
- Young Adult
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.